Loading company…
Xin Heng Rui develops cardiac assist devices, including percutaneous ventricular assist systems.
Founded in 2021 and based in Shanghai, Xin Heng Rui develops medical devices that support cardiac function. Its core product is the Omniheart percutaneous ventricular assist device, which includes an implanted motor and safety monitoring system. In July 2023, the company raised approximately CNY 100 million in Series A funding led by IDG Capital, with Everest and Huaige Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in